For short half-lives (less than 7 hours) this is very similar to the environmental variability.
IMPACT OF BIOLOGICAL AND ENVIRONMENTAL VARIABILITIES ON BIOLOGICAL MONITORING. AN APPROACH USING TOXICOKINETIC MODELS
A
INTRODUCTION
Occupational exposure assessment is an important step in managing chemical exposure in the workplace. Because inhalation is often the predominant route of exposure, this assessment very often relies on measurements of the air which workers are breathing. In many instances, biological monitoring of exposure is also used, and this is considered to better represent exposure because it takes into account such factors as the physical workload, other exposure routes, and differences in distribution and metabolism. (1, 2) Air monitoring results have been shown to present important variability whether repeated measurements are taken for the same worker, the same workplace or the same industry. (3, 4) This variability can be divided into within-worker variability (the same worker from day to day) and between-worker variability (differences in long term average exposure between workers). (5) When using biological monitoring data an additional source of variability has to be considered: individual variability due to physiological and biochemical differences both within and between workers. This aspect was recently studied by our group for a number of chemical agents using physiologically based toxicokinetic and compartmental toxicokinetic models. (6, 7) In field situations, biological monitoring results are thus affected by both individual variability and environmental variability. Based on the analysis of a large database of occupational and environmental biological and air monitoring measurements, Lin et al . (4) demonstrated that biological data show less variability than air sampling results. This was further shown to be associated with the kinetics of the biological indicator. Similar trends were obtained in a previous study using simple toxicokinetic considerations.
These exploratory analyses were made in the context of retrospective exposure assessment for epidemiological studies.
An in depth description and understanding of the simultaneous effects of the environmental and individual variability on the bioindicators also appears to be recommended for the practical application of biological monitoring techniques. The conclusion which can be drawn from the results obtained and the decisions as to which monitoring technique should be used in a particular situation are important parts of the exposure assessment process. Thus, it is important to have a good understanding of the associated variability for the application of biological monitoring in the evaluation of current occupational exposure. This was previously described for exposures at steady concentrations (i.e. considering only individual variability) using physiologically based toxicokinetic modelling (PBTK) and compartmental toxicokinetic models. (9, 10) The purpose of the present study was to extend the application of the compartmental toxicokinetic models to include environmental variability in the discussion of biological monitoring variability.
Using toxicokinetic tools developed previously by our group (10) , the objective of this paper is to describe the total variability observed in biological monitoring results under field conditions as a function of environmental and individual variability. This approach was applied to 14 widely used chemical compounds and their twenty related biological indicators.
METHODS

Model Description
A compartmental based toxicokinetic (CBTK) model developed for several chemicals in a previous study (10) was used to assess the effect of individual and environmental variability on bioindicator results. The model structure, presented in Figure 1 , is a compromise between the detailed biological processes and the availability of data for a wide range of chemicals. This generic model was applied to 14 chemicals chosen from the IRSST's guide to corresponding biological indicators. Specifically, the chemicals were: arsenic, cadmium, carbon monoxide, chromium, cobalt, ethylbenzene, ethyleneglycol monomethylether, fluorides, lead, mercury, methyl isobutyl ketone (MIBK), penthachlorophenol, phenol and toluene. Physiological, physicochemical, biochemical and kinetic data were used to simulate the behavior of each chemical in the human body. The values of the model parameters were modulated according to each compound's basic data.
The generic CBTK model is composed of two compartments: central (C) and peripheral (P) physiological compartments. Elimination is represented by two kinetic relationships: for the primary metabolite (M 1 ) and the secondary metabolite (M 2 ). (10) However, the number of compartments used depends on the chemical, it may vary from one to four depending on the available data on the compound and its toxicokinetic behavior.
In these models, the absorption, excretion and exchanges between compartments are described by flows. Uptake occurs in compartment C. The initial substance is then distributed to compartment P according to the blood flow (BF) rate, the estimated volume of the compartment (e.g. kidney or liver volume), the partition coefficients, and the compartment burden. This distribution also depends on the permeability of the tissue to the substance and it can therefore be perfusion or diffusion limited. The transfer between the compartment C and the metabolite compartments is described by the metabolic clearance. The flux between the compartment C and metabolites is calculated as a function of the organ's blood flow, the Michaelis-Menten constant, and the maximum rate of metabolism. It was considered to be a first-order kinetic in the range of concentrations obtained during the exposures which we simulated, as they are in most cases low and limited in range (a factor of 10, at most). The model structure also allows the description of the transformation of one metabolite into another, i.e. serial metabolism. In this case, the kinetics of the secondary metabolite depends on the burden of primary metabolite and on its metabolic clearance. Finally, elimination is considered to occur through pulmonary, fecal and urinary excretion, as well as by metabolism.
The general structure of the model was adapted for each substance selected with regards to the known metabolites, and the available data concerning physiological and biochemical mechanisms. Model mathematical equations have been presented and discussed previously (10) .
Model Parameters
Models were established using physiological and biochemical parameters. The specific structure and data used for each chemical are presented in detail in Table IV (Appendix). This indicates which compartments were considered and the specific parameters used for the chemical of interest. Generic parameters are presented in Table I : cardiac output, alveolar ventilation, body weight, creatinine excretion and urine output. These were taken to vary as a power function of body weight. Table I also displays coefficients of variation (CV) and parameter distributions for biological parameters considered as random variables. They were selected from a literature review or from data of Thomas et al. (13) . These random variables were then used to calculate the parameters specific to each chemical as presented in Table IV (Appendix).
In some cases, parameters determining the flows had to be estimated from elimination halflife (t½) and sometimes compartment steady-state concentrations. Depending on the chemical, specific parameters estimated were: tissue volume, tissue permeability, and urinary and feces excretion rate constants.
All data used in the specific models are summarized in Table IV , together with a description of the compartments used. We initially searched for useful basic toxicokinetic information in review articles (14, 15, 16) , and further specific information was extracted from other literature (see footnotes in Table IV (Appendix)).
Model Evaluation
Results from the model were compared to actual concentrations measured in humans, notably under conditions representative of occupational exposure. No formal evaluation was made. Best fit was not attempted, but a reasonable correlation was looked for by visually comparing results with measured data at different time points. To validate the models, we estimated what biological concentrations would be following repeated exposure at the occupational exposure limit (OEL). The results obtained at specified sampling times were compared to corresponding biological exposure indices (BEI) (14) . Although, by definition, the latter are not directly linked to OEL, in most cases they represent a good estimation of real life exposure.
Monte Carlo Simulations
After obtaining a valid model for an average worker, for a given chemical, the second step consists of simulating different scenarios (different individuals, different exposure conditions, etc.). The simulations modeled workers carrying out a physical activity of 50 Watts for 12 hours per day (eight hours of work activity with exposure followed by four hours of activity outside work). This was followed by a rest period of 12 hours. A normal week consisted of five successive days of eight hours exposure followed by two unexposed days. The parameters dependant on physical activity (cardiac output, alveolar ventilation, organ blood flows, etc.) were adjusted to correspond to this daily pattern.
The data set was generated by two-dimensional (2D) Monte Carlo simulations. This model simulated both uncertainty and variability in distribution parameters, unlike onedimensional Monte Carlo (1D) analysis that would model either uncertainty or variability in input variable. ( 
17)
The software used for programming the simulation was SAS V9.1 (SAS Institute Inc). The modeling equations were solved using the Euler method. Previous studies have presented these in detail. (10) Sample Size
In order to optimize modeling studies, preliminary simulations were done to estimate the minimum number of simulated days (sample) required to represent the statistical parameters of a population with a given confidence interval. These preliminary simulations were run for chemicals on the BEI which had shown the most variability in previous studies. (6, 7) The population was described by simulating a group of 500 similar workers subject to 100 weeks of exposure, with an average exposure variability (GSD of 2.0). Exposure was fixed so that 95% of daily exposures were below the OEL. The 50,000 observations collected (one biological sample taken each week, for each worker) were computed and statistically analyzed to determine the population variance (s²). The minimum required sample, size N (uncorrected sample size estimate), was calculated with a target precision level "B" (18) such that:
B is expressed as half of the maximum acceptable confidence interval width. At the end-of-shift exposure analysis, the most variable biological indicator proved to be toluene in the blood. To ensure a statistically representative estimation of the "50,000" population distribution, with a 10% precision level, the resulting sample size was 229 weeks. The number of observations was thus fixed at 300 weeks for all chemicals, corresponding to a total of 1,500 daily exposures generated randomly.
Exposure Scenarios
Three types of output parameters are required to assess the variability of bioindicators: the biological variability (BV B ), the environmental biological variability (BV E ) and the total variability (BV T ).
The BV B is defined as the variability in the bioindicators associated with variations in physiological parameters between workers in a constant exposure scenario. In this study, individual within-worker variability was considered much smaller than between-worker variability and for simplicity was therefore ignored (no intra-individual biological variability). (19) The BV E is defined as the variability in the biological indicators due to the variations in the exposure scenario for a given worker exposed to stable ambient concentrations during the day, but varying day to day. This was simulated by the exposure of the average worker for 300 weeks, using two exposure patterns (GSD of 1.5 and GSD of 2.0). Thus, in this case the environmental variability was the only influence on biological monitoring. The GSD of 1.5 and GSD of 2.0 were chosen to represent typical low and average environmental variabilities.
The BV T is defined as the variability of the bioindicator data in a group of workers exposed to varying daily concentrations. This represents the combined BV B and BV E . This was estimated by simulating 500 biologically different workers exposed to varying airborne concentrations over 1,500 days.
Statistical Analysis
The results obtained in the different scenarios for the various biological indicators were statistically analyzed using SAS V9.1. The normality of the data distributions and of the logarithmically transformed data were verified using the Kolmogorov-Smirnov-Goodness-of-fit
Test. The skewness and the kurtosis were estimated for each distribution. Descriptive geometric statistics (geometric mean, GSD and the lower and upper limits of confidence intervals) were also compiled for each biological indicator distribution.
To facilitate the analysis and the use of the results, the Upper Confidence Index (UCI) was calculated. This can be used to assess the upper confidence limit UCL 95 associated with a biological monitoring result (RS), for each biological indicator:
where ii could represent BV E , BV B or BV T , and n is the number of measurements completed (if n 1, RS is the geometrical mean). Table II shows the biological concentrations obtained for exposures at the OEL with the CBTK model using general data from Table I and chemical-specific information from Table IV (Appendix). The data shown are for sampling times and biological fluids specified for the given BEI. On average, the CBTK model overestimates the corresponding BEIs by 12%, with a range from -35 to 105%. A fair correlation was obtained between predicted results and the recommended BEIs, except for with methyl isobutyl ketone (MIBK). The discrepancy for MIBK (105% higher than the BEI) might also come from uncertainties in the BEI value itself, as indicated by the higher limit value (35 mmol/l) proposed in Germany. (21) A simple compartmental model, based on accessible physiological, physico-chemical and biochemical data, can thus be used to predict biological levels corresponding fairly accurately to OELs.
RESULTS AND DISCUSSION
Predicting BEIs with the CBTK Model
Furthermore, results rest on a realistic representation of the model, thus we can be confident in their mean and variability results. The model requires not more than 12
parameters which can be estimated from physiological and metabolic information. Such models could easily be applied to other less studied chemicals to gather information on potential biological levels at the OEL, and their associated variability.
Biological Variability
According to the Kolmogorov-Smirnov test, the majority of the distributions obtained for the different biological indicators in the different exposure scenarios were lognormal. After logarithmic transformation, distributions proved to be normal, with nearly no skewness or kurtosis, except for cadmium (GSD of 1.5 and GSD of 2.0) and for fluorides (GSD of 1.5).
Indeed, these two BEIs did not fit a normal distribution after logarithmic transformation of data, and skewness and kurtosis were very high in some cases. It must be noted that these two biological indicators have very long half-lives, which could explain the non-lognormal behavior.
In this case, biological levels likely represent more long term mean exposure than current exposure (or at least a mix of long term and recent exposure) and are therefore minimally influenced by the lognormal daily fluctuations in exposure concentration (especially in the case of a GSD of 1.5).
The results of the estimated variabilities are reported in Table III total biological variability will, in practice, be a combination of BV B and BV E , and could in some cases be larger than exposure variability itself. Table III also suggest that there is a link between the predicted BV E and the biological half-lives. This is further illustrated in Figure 2 , where dominant half-life is compared to BV E .
Data in
The variability in the biological indicators due to the variations in the exposure scenario tends to decrease with the chemical half-life. This is in qualitative agreement with what was previously shown in a simple one-compartment model (8) and should be taken into account when interpreting biological monitoring data, and defining an action level to take decisions. These results suggest that using biological monitoring does not offer a significant advantage for chemicals with short half-life. That is particularly true for chemical with a half-life shorter than the duration of a work day. As a matter of fact, the exposure model used in this paper assumes stable ambient concentrations during the day. In real-life conditions, the ambient concentrations may vary greatly throughout the day and hence increase the biological variability of chemicals with short half-lives. For other biological indicators with half-lives of more than 24 hours (e.g. blood lead), there is a substantial reduction of variability, making the estimation of long term mean exposure statistically more efficient. According to results from Table III , environmental monitoring seems to be the approach to favor when working environments present small fluctuations in the contaminants studied at ambient levels, except when they have long half-lives in blood. In that exception, the measurement of biological indicators could be better than environmental monitoring because of the smoothing effect of biological indicators with long half-lives.
CONCLUSION
Furthermore, Droz and Wu (8) drew a similar conclusion; biological monitoring is the best method when there are significant fluctuations in the ambient levels of exposure and when parameters have a half-life longer than 10 hours. Likewise, the studies by Rappaport et al. (22) and Symanski et al. (23) emphase that biological monitoring data, estimated on the basis of measurements of bioindicators with long half-lives, appear to be less variable than air monitoring data, whereas the latter is the best approach to adopt for compounds with short half-lives. The decision to adopt biological monitoring should not only rest on variability associated with indicator measurements, but should also take into account the toxicological significance of the biological parameter. The utility of biological monitoring will rest on whether this variability reflects differences in the level of the risk incurred. In spite of the risk of great variability, other situations can also justify the use of alternatives to biological monitoring.
Moreover
The present study did not take into consideration the simulation of intra-individual variability (biological changes from one day to the next). This was judged to be less important than inter-individual variability. (19) This issue should be considered in further work so as to complete the picture on variability.
The variability data obtained in the present study can be used in order to calculate the number of biological samples required to acquire a given degree of confidence to support decision-making. The information presented here should be used as a basis for the development of biological monitoring strategies.
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